AFB-Xpert panel by Combo (MTB /RIF Detection & AFB Culture) - Extrapulmonary Samples

The AFB-Xpert panel by Combo (MTB/RIF Detection & AFB Culture) is a comprehensive diagnostic approach designed for extrapulmonary samples, aiming to detect the presence of Mycobacterium tuberculosis (MTB) and assess rifampicin resistance. This panel offers a combined strategy utilizing both molecular testing and culture methods. The MTB/RIF Detection component employs the Xpert assay to rapidly identify MTB DNA and simultaneously determine rifampicin resistance, a key indicator of multidrug-resistant TB. The AFB Culture aspect further enhances the diagnostic process by cultivating MTB in a controlled environment, allowing for subsequent drug susceptibility testing. The clinical utility of this panel lies in its ability to provide timely and accurate results, facilitating the prompt detection of MTB infection and rifampicin resistance assessment in extrapulmonary cases. This information is crucial for effective treatment planning and the management of tuberculosis in various clinical scenarios.